Fasciitis induced by sintilimab in a patient with recurrent hepatocellular carcinoma

Eur J Cancer. 2021 Sep:155:296-298. doi: 10.1016/j.ejca.2021.06.046. Epub 2021 Aug 4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Carcinoma, Hepatocellular / complications*
  • Carcinoma, Hepatocellular / drug therapy
  • Fasciitis / chemically induced*
  • Humans
  • Liver Neoplasms / complications*
  • Liver Neoplasms / drug therapy
  • Male
  • Middle Aged

Substances

  • Antibodies, Monoclonal, Humanized
  • sintilimab